Akèy › Kolit Ulseratif › Texas › Lubbock
Etid klinik pou Kolit Ulseratif nan Lubbock, TX
9 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Lubbock (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- West Texas Research Institute, Lubbock
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Site US-015, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ap rekriteFaz 1/2Volontè an sante akeyi
- Xencor Investigative Site, Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Ap rekriteFaz 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Ap rekriteFaz 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Lubbock
Etid Kolit Ulseratif nan lòt vil
- New York City, NY24 etid
- Orlando, FL23 etid
- Miami, FL22 etid
- Houston, TX18 etid
- San Antonio, TX16 etid
- San Diego, CA16 etid
- Tacoma, WA15 etid
- Chicago, IL15 etid
- Colorado Springs, CO14 etid
- St. Louis, MO14 etid
- Tyler, TX14 etid
- Los Angeles, CA13 etid
Lòt etid nan Lubbock
- Maladi Crohn10 etid
- Kansè nan tete6 etid
- Kansè Poumon ki pa ti selil4 etid
- Myelom Miltip3 etid
- Atrit psoryatik3 etid
- Sipwa3 etid
- Obèsite3 etid
- Limfòm Burkitt3 etid
- Maladi Entestinal Anflamatwa3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.